AP486A - Indole derivatives. - Google Patents

Indole derivatives. Download PDF

Info

Publication number
AP486A
AP486A APAP/P/1994/000633A AP9400633A AP486A AP 486 A AP486 A AP 486A AP 9400633 A AP9400633 A AP 9400633A AP 486 A AP486 A AP 486A
Authority
AP
ARIPO
Prior art keywords
treating
indole
methylaminosulfonylmethyl
ranging
amount
Prior art date
Application number
APAP/P/1994/000633A
Other languages
English (en)
Other versions
AP9400633A0 (en
Inventor
John Eugene Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP9400633A0 publication Critical patent/AP9400633A0/xx
Application granted granted Critical
Publication of AP486A publication Critical patent/AP486A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
APAP/P/1994/000633A 1993-04-27 1994-04-07 Indole derivatives. AP486A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5393093A 1993-04-27 1993-04-27

Publications (2)

Publication Number Publication Date
AP9400633A0 AP9400633A0 (en) 1994-04-30
AP486A true AP486A (en) 1996-04-16

Family

ID=21987528

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000633A AP486A (en) 1993-04-27 1994-04-07 Indole derivatives.

Country Status (29)

Country Link
EP (1) EP0696194B1 (no)
JP (1) JP2922307B2 (no)
KR (1) KR960701636A (no)
CN (3) CN1515252A (no)
AP (1) AP486A (no)
AT (1) ATE222492T1 (no)
AU (1) AU689469B2 (no)
BG (1) BG61898B1 (no)
BR (1) BR9406435A (no)
CA (1) CA2161533C (no)
CO (1) CO4230093A1 (no)
CZ (1) CZ290416B6 (no)
DE (1) DE69431201T2 (no)
DK (1) DK0696194T3 (no)
ES (1) ES2180573T3 (no)
HU (1) HU222488B1 (no)
IL (1) IL109376A (no)
MX (1) MX9403088A (no)
NO (1) NO308236B1 (no)
NZ (1) NZ263614A (no)
OA (1) OA10189A (no)
PL (1) PL175156B1 (no)
PT (1) PT696194E (no)
RO (1) RO117760B1 (no)
RU (1) RU2132683C1 (no)
SG (1) SG43951A1 (no)
SK (1) SK283353B6 (no)
WO (1) WO1994025023A1 (no)
ZA (1) ZA942805B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
AU686654B2 (en) * 1993-08-31 1998-02-12 Pfizer Inc. 5-arylindole derivatives
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
ATE224388T1 (de) * 1994-10-12 2002-10-15 Pfizer Res & Dev Indolderivate zur behandlung von migräne
GB9424471D0 (en) * 1994-12-03 1995-01-18 Pfizer Ltd Treatment of emesis
GB9510223D0 (en) * 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent
US5945118A (en) * 1995-09-29 1999-08-31 Pfizer Inc Indole derivative for the treatment of migraine
US5773015A (en) * 1996-11-27 1998-06-30 Elizabeth Arden Co., Division Of Conopco, Inc. Method for controlling skin oils and grease
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
KR20220137085A (ko) * 2020-02-04 2022-10-11 마인드셋 파마 인크. Cns 장애의 치료를 위한 세로토닌성 사이키델릭 작용제로서의 3-피롤리딘-인돌 유도체

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006973A1 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Indole derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006973A1 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Indole derivatives

Also Published As

Publication number Publication date
EP0696194A1 (en) 1996-02-14
RU2132683C1 (ru) 1999-07-10
RO117760B1 (ro) 2002-07-30
DE69431201T2 (de) 2002-12-05
NO954287D0 (no) 1995-10-26
AP9400633A0 (en) 1994-04-30
SK283353B6 (sk) 2003-06-03
HUT73670A (en) 1996-09-30
ES2180573T3 (es) 2003-02-16
NO954287L (no) 1995-10-26
CZ9502802A3 (en) 1996-04-17
CN1121689A (zh) 1996-05-01
HU222488B1 (hu) 2003-07-28
AU6436094A (en) 1994-11-21
IL109376A0 (en) 1994-07-31
HU9503089D0 (en) 1995-12-28
ZA942805B (en) 1995-10-23
CO4230093A1 (es) 1995-10-19
NZ263614A (en) 1998-02-26
WO1994025023A1 (en) 1994-11-10
PL311266A1 (en) 1996-02-05
MX9403088A (es) 1997-02-28
JP2922307B2 (ja) 1999-07-19
BR9406435A (pt) 1996-01-09
CZ290416B6 (cs) 2002-07-17
DE69431201D1 (de) 2002-09-26
PL175156B1 (pl) 1998-11-30
CN1515252A (zh) 2004-07-28
PT696194E (pt) 2002-11-29
ATE222492T1 (de) 2002-09-15
IL109376A (en) 2000-10-31
DK0696194T3 (da) 2002-10-07
BG100093A (bg) 1996-04-30
KR960701636A (ko) 1996-03-28
NO308236B1 (no) 2000-08-21
OA10189A (en) 1996-12-18
SG43951A1 (en) 1997-11-14
AU689469B2 (en) 1998-04-02
EP0696194B1 (en) 2002-08-21
CN1509713A (zh) 2004-07-07
JPH08504829A (ja) 1996-05-28
SK133295A3 (en) 1997-01-08
CA2161533C (en) 1998-08-04
CA2161533A1 (en) 1994-11-10
BG61898B1 (bg) 1998-09-30

Similar Documents

Publication Publication Date Title
AP486A (en) Indole derivatives.
US6512002B2 (en) Methods of treatment for premature ejaculation in a male
WO1994025023A9 (en) Use of indole derivatives as 5ht1 antagonists
JPH09508137A (ja) セロトニンアゴニストおよびアンタゴニストとしての４−インドール誘導体
IL87658A (en) Tetrahydro-H-) -12-imidazolylmethyl (pyrido-) and azapino- (] B) -4,3 ([indole-1-ointments, their preparation and pharmaceutical preparations containing them
JPH02167280A (ja) ラクタム誘導体
AU627769B2 (en) The use of lactam derivatives in the treatment of cognitive disorders
CA2213241C (en) Indole derivative for the treatment of migraine
JPS6335570A (ja) ヘテロ環式化合物
AU627770B2 (en) The use of lactam derivatives in the treatment of depression
US5945118A (en) Indole derivative for the treatment of migraine
US5229407A (en) Medicaments
US5221687A (en) Medicaments
JPH02180823A (ja) 医薬
US5276050A (en) Medicaments
JPH07503240A (ja) ３‐アリールインドールおよび１‐アリールインダゾール誘導体の精神病の治療のための使用
EP0411901A2 (en) Treatment of conditions involving excessive eating